AbbVie’s Battle Over Alvotech’s Humira Biosimilar Moves To New Ground With ITC Investigation

 
• By Brenda Sandburg

International Trade Commission launches investigation of adalimumab manufacturing processes in response to AbbVie complaint of misappropriation of trade secrets. District court dismissed trade secret suit on grounds it lacked jurisdiction. Trial in infringement suit is set for August.

International Trade Commission
ITC institutes investigation of manufacturing process for Alvotech's Humira biosimilar • Source: Alamy

More from Biosimilars

More from Products